MedPath

Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy.

Not Applicable
Completed
Conditions
Pregnancy Test
Registration Number
NCT03184519
Lead Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Brief Summary

Proof of concept study for the prediction of ongoing pregnancy in women undergoing In-Vitro Fertilization (IVF), using hyperglycosylated human chorionic gonadotropin (hhCG), early after In-Vitro Fertilization and fresh Embryo Transfer (IVF-ET).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
156
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of Participants With Early Detection of PregnancyOne month

Detection of Pregnancy on earlier dates (before day-11 after Embrio transfer)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

IVI Valencia

🇪🇸

Valencia, Spain

IVI Valencia
🇪🇸Valencia, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.